This study investigates the intricate relationship between brain dopamine-clock interactions and their impact on cardiometabolic physiology, with a particular focus on elucidating the mechanisms underlying the observed cardioprotective effects of circadian-timed Bromocriptine-QR therapy in individuals with Type 2 Diabetes. The circadian rhythm plays a pivotal role in regulating various physiological processes, including metabolism and cardiovascular health. Through a comprehensive analysis of the interplay between brain dopamine pathways and the circadian clock, we aim to provide insights into the therapeutic potential of timing medication administration to align with the body's natural rhythms. Our findings shed light on the intricate web of molecular and physiological mechanisms governing this interaction, offering new perspectives for optimizing treatment strategies in Type 2 Diabetes management while promoting cardiovascular health.
HTML PDFShare this article
Epilepsy Journal received 41 citations as per Google Scholar report
